Genetics and familial distribution of multiple sclerosis: A review

A Balcerac, C Louapre - Revue Neurologique, 2022 - Elsevier
Purpose of review This article reviews the genetics of multiple sclerosis (MS), as well as intra-
familial concordance and clinical correlations between different members of a family …

MicroRNAs as active players in the pathogenesis of multiple sclerosis

C Fenoglio, E Ridolfi, D Galimberti… - International journal of …, 2012 - mdpi.com
MicroRNAs (miRNAs) are a recently discovered group of small noncoding RNAs that
regulate gene expression post-transcriptionally. They are highly expressed in cells of the …

Disease-modifying treatments for progressive multiple sclerosis

G Comi - Multiple Sclerosis Journal, 2013 - journals.sagepub.com
The last 20 years have seen major progress in the treatment of relapsing–remitting multiple
sclerosis (RRMS) using a variety of drugs targeting immune dysfunction. In contrast, all …

[HTML][HTML] Genetics of multiple sclerosis

IA Hoppenbrouwers, RQ Hintzen - … Acta (BBA)-Molecular Basis of Disease, 2011 - Elsevier
A genetic contribution to MS pathogenesis has been proven ever since the association with
the HLA-DR2 locus was discovered more than 30 years ago. The search for additional MS …

[HTML][HTML] Risk conferring genes in multiple sclerosis

S Nischwitz, B Müller-Myhsok, F Weber - FEBS letters, 2011 - Elsevier
Multiple sclerosis (MS) is characterized by inflammation, axonal and oligodendrocyte
pathology and progressive neurological disability. Epidemiologic data indicate that MS may …

Molecular Motors in Myelination and Their Misregulation in Disease

DJ Barbosa, C Carvalho, I Costa, R Silva - Molecular Neurobiology, 2024 - Springer
Molecular motors are cellular components involved in the intracellular transport of
organelles and materials to ensure cell homeostasis. This is particularly relevant in neurons …

Genetics of primary progressive multiple sclerosis

BAC Cree - Handbook of clinical neurology, 2014 - Elsevier
Multiple sclerosis (MS) patients are classified as either having relapsing onset or
progressive onset disease, also known as primary progressive MS (PPMS). Relative to …

When is the absence of evidence, evidence of absence? Use of equivalence‐based analyses in genetic epidemiology and a conclusion for the KIF1B rs10492972*C …

PA Gourraud… - Genetic …, 2011 - Wiley Online Library
Statistical equivalence methods have been in development since the late 1980s in order to
provide an appropriate statistical methodology to address nondifferences in biological …

Perspectives on the use of multiple sclerosis risk genes for prediction

N Jafari, L Broer, CM van Duijn, ACJW Janssens… - Plos one, 2011 - journals.plos.org
Objective A recent collaborative genome-wide association study replicated a large number
of susceptibility loci and identified novel loci. This increase in known multiple sclerosis (MS) …

[图书][B] Нейроиммунные механизмы патогенеза рассеянного склероза

ИА Гольдина, ЕВ Маркова - 2018 - elibrary.ru
Монография посвящена современным аспектам нейроиммунных механизмов
формирования патологического процесса в нервной системе при рассеянном склерозе …